Announcements Trials
Browse Landscape

Phase

Phase 1 70Phase 2 55Phase 1/2 37Phase 3 13Phase NA 11Phase EARLY_PHASE1 6Phase 2/3 4Phase 4 2

Status

Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 11Gastrointestinal 10Other hematologic neoplasm 8Plasma cell 3Genitourinary 3Gynecologic 2Classical hematology 2CNS 2Thoracic 1Sarcoma 1Myeloid 1Head & Neck 1

Conditions

Brain Neoplasms 34Glioblastoma 8Glioma 7Meningeal Carcinomatosis 6Epilepsy 5Neuroblastoma 4Neoplasms 4Neoplasm Metastasis 4Pituitary Neoplasms 3Meningioma 3Melanoma 3Lung Neoplasms 3Breast Neoplasms 3Seizures 2Retinoblastoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Paraganglioma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 1 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Delirium 2Central Nervous System Diseases 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Wilms Tumor 1Stroke 1

Interventions

Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recurrence × CNS × Clear all
NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn
CNS

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01756729 2016-03-02

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

NovoCure Ltd.

Phase 4 Terminated
13 enrolled
CNS

Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡